Susi Roger E.'s Form 4 filing
Iradimed Corp (IRMD) · filed Mar 25, 2026
- Accession no.
- 0001613801-26-000018
- Filed
- Mar 25, 2026
- Trade date
- Mar 23-24, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $752.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Susi Roger E.CIK 0001613801 | Director, Officer (CEO, PRESIDENT, CHAIRMAN), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Common Stock | SSaleDisposed | −2,950 | $99.58F2 | −$293,761 | 2,237,050 | Indirect | |
| Mar 23, 2026 | Common Stock | SSaleDisposed | −750 | $100.70F3 | −$75,525 | 2,236,300 | Indirect | |
| Mar 23, 2026 | Common Stock | SSaleDisposed | −1,300 | $102.02F4 | −$132,626 | 2,235,000 | Indirect | |
| Mar 24, 2026 | Common Stock | SSaleDisposed | −1,585 | $100.03F5 | −$158,547.55 | 2,233,415 | Indirect | |
| Mar 24, 2026 | Common Stock | SSaleDisposed | −915 | $100.71F6 | −$92,149.65 | 2,232,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $99.02 to $100.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $100.05 to $100.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $102.00 to $102.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $99.49 to $100.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $100.53 to $100.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.